… We conducted a retrospective multicenter trial to determine the significance of clinical factors
as predictors of nivolumab efficacy in patients with advanced NSCLC. Particular attention …

… In this retrospective study, … lung cancer was the only variable that was significantly associated
with a longer survival (p = 0.02). In our study patients with non-squamous cell carcinoma …

… for lung cancer development. Our results present with inherent weaknesses of a retrospective
study, … Nevertheless, this study provides pivotal data that lung cancer is prevalent in a large …

… In this retrospective multicenter study, we developed CT-based DL models for the prognostication
of early-stage lung adenocarcinomas. The models were trained to predict VPI and LVI, …

… the largest, multicentre study for patients with IPF and lung cancer at a pan-European level.
Our study exhibited several important attributes. First, we demonstrated that lung cancer was …

… Adenocarcinoma of the ethmoid is a rare lesion. This retrospective multicenter study … The
factors influencing the survey are predominantly the size of lesion (T4), extension to the lymph …

… lung disease in patients treated with osimertinib after treatment with anti-PD-1 antibody.23-25
In this study, neither did any patient have interstitial lung … similar retrospective studies of …

… The primary focus of this observational, retrospective, multicenter trial was overall survival
(OS). Secondary end points were progression-free survival (PFS) and objective response rate (…

… Lung Cancer Clinical Study Group Trial 2002 (HOT2002) was a retrospective, observational,
multicenter study … The objective of this study was to describe the clinical characteristics and …

… We retrospectively included 129 patients with RET-rearranged lung cancer from 13 centers.
The majority of patients presented stage III–IV disease at initial diagnosis (n = 110, 85.3%). …